Complete Response to a Fibroblast Growth Factor Receptor Inhibitor in a Patient With Head and Neck Squamous Cell Carcinoma Harboring FGF Amplifications

被引：15

作者：

Dumbrava, Ecaterina Ileana ^{[1
]}

Alfattal, Rash A. ^{[1
]}

Miller, Vincent A. ^{[2
]}

Tsimberidou, Apostolia Maria ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Fdn Med, Cambridge, MA USA

来源：

JCO PRECISION ONCOLOGY | 2018年 / 2卷

关键词：

ADVANCED SOLID TUMORS; GENETIC ALTERATIONS; DOSE-ESCALATION; PHASE-I; AZD4547; FUSIONS; TARGET; SAFETY; ROLES;

D O I：

10.1200/PO.18.00100

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1 / 7

页数：7

共 34 条

[1] Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma [J].

Borad, Mitesh J. ;

Champion, Mia D. ;

Egan, Jan B. ;

Liang, Winnie S. ;

Fonseca, Rafael ;

Bryce, Alan H. ;

McCullough, Ann E. ;

Barrett, Michael T. ;

Hunt, Katherine ;

Patel, Maitray D. ;

Young, Scott W. ;

Collins, Joseph M. ;

Silva, Alvin C. ;

Condjella, Rachel M. ;

Block, Matthew ;

McWilliams, Robert R. ;

Lazaridis, Konstantinos N. ;

Klee, Eric W. ;

Bible, Keith C. ;

Harris, Pamela ;

Oliver, Gavin R. ;

Bhavsar, Jaysheel D. ;

Nair, Asha A. ;

Middha, Sumit ;

Asmann, Yan ;

Kocher, Jean-Pierre ;

Schahl, Kimberly ;

Kipp, Benjamin R. ;

Fritcher, Emily G. Barr ;

Baker, Angela ;

Aldrich, Jessica ;

Kurdoglu, Ahmet ;

Izatt, Tyler ;

Christoforides, Alexis ;

Cherni, Irene ;

Nasser, Sara ;

Reiman, Rebecca ;

Phillips, Lori ;

McDonald, Jackie ;

Adkins, Jonathan ;

Mastrian, Stephen D. ;

Placek, Pamela ;

Watanabe, Aprill T. ;

LoBello, Janine ;

Han, Haiyong ;

Von Hoff, Daniel ;

Craig, David W. ;

Stewart, A. Keith ;

Carpten, John D. .

PLOS GENETICS, 2014, 10 (02)

[2] Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application [J].

Chae, Young Kwang ;

Ranganath, Keerthi ;

Hammerman, Peter S. ;

Vaklavas, Christos ;

Mohindra, Nisha ;

Kalyan, Aparna ;

Matsangou, Maria ;

Costa, Ricardo ;

Carneiro, Benedito ;

Villaflor, Victoria M. ;

Cristofanilli, Massimo ;

Giles, Francis J. .

ONCOTARGET, 2017, 8 (09) :16052-16074

[3] Ponatinib (AP24534), a Multitargeted Pan-FGFR Inhibitor with Activity in Multiple FGFR-Amplified or Mutated Cancer Models [J].

Gozgit, Joseph M. ;

Wong, Matthew J. ;

Moran, Lauren ;

Wardwell, Scott ;

Mohemmad, Qurish K. ;

Narasimhan, Narayana I. ;

Shakespeare, William C. ;

Wang, Frank ;

Clackson, Tim ;

Rivera, Victor M. .

MOLECULAR CANCER THERAPEUTICS, 2012, 11 (03) :690-699

[4] FGFR Genetic Alterations Predict for Sensitivity to NVP-BGJ398, a Selective Pan-FGFR Inhibitor [J].

Guagnano, Vito ;

Kauffmann, Audrey ;

Woehrle, Simon ;

Stamm, Christelle ;

Ito, Moriko ;

Barys, Louise ;

Pornon, Astrid ;

Yao, Yao ;

Li, Fang ;

Zhang, Yun ;

Chen, Zhi ;

Wilson, Christopher J. ;

Bordas, Vincent ;

Le Douget, Mickael ;

Gaither, L. Alex ;

Borawski, Jason ;

Monahan, John E. ;

Venkatesan, Kavitha ;

Bruemmendorf, Thomas ;

Thomas, David M. ;

Garcia-Echeverria, Carlos ;

Hofmann, Francesco ;

Sellers, William R. ;

Graus-Porta, Diana .

CANCER DISCOVERY, 2012, 2 (12) :1118-1133

[5] Roles of Fibroblast Growth Factor Receptors in Carcinogenesis [J].

Haugsten, Ellen Margrethe ;

Wiedlocha, Antoni ;

Olsnes, Sjur ;

Wesche, Jorgen .

MOLECULAR CANCER RESEARCH, 2010, 8 (11) :1439-1452

[6] Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid Tumors [J].

Hierro, Cinta ;

Rodon, Jordi ;

Tabernero, Josep .

SEMINARS IN ONCOLOGY, 2015, 42 (06) :801-819

[7] Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease [J].

Itoh, Nobuyuki ;

Ornitz, David M. .

JOURNAL OF BIOCHEMISTRY, 2011, 149 (02) :121-130

[8]

Katoh M, 2005, INT J ONCOL, V27, P281

[9] FGF Receptors: Cancer Biology and Therapeutics [J].

Katoh, Masaru ;

Nakagama, Hitoshi .

MEDICINAL RESEARCH REVIEWS, 2014, 34 (02) :280-300

[10] The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer [J].

Kono, Scott A. ;

Marshall, Marianne E. ;

Ware, Kathryn E. ;

Heasley, Lynn E. .

DRUG RESISTANCE UPDATES, 2009, 12 (4-5) :95-102

← 1 2 3 4 →